CHEK2 and urothelial carcinoma: Moreover, increased numbers of germline variants associated with DNA damage repair pathways in human urothelial carcinoma (UC) patients (e.g. BRCA1/2, CHEK2, and ATM), particularly in BRCA210,41 have led one group to call for BRCA2 germline UC screenings41.